Abstract
PURPOSE. To report two cases of intraocular hypertension after intravitreal injection of triamcinolone acetonide (iTAA) that were refractory to maximal medical therapy and were successfully treated with argon laser trabeculoplasty (ALT). METHODS. Two patients with history of primary open angle glaucoma were treated with intravitreal injection of triamcinolone acetonide for chronic macular edema secondary to branch retinal vein occlusion. Both patients (Case 1 after 2 months and Case 2 after 5 days) developed intraocular hypertension that did not respond to maximal medical therapy. Despite medical therapy, intraocular pressure (IOP) was 45 mmHg in Case 1 and between 34 and 37 mmHg in Case 2. ALT was performed in the inferior 180° angle using the following parameters: 50 μm size, 700 mW, 0.50 sec, 100 spots. RESULTS. In both patients IOP returned to normal level a few days after ALT. CONCLUSIONS. ALT seems to be effective at reducing IOP in patients with intraocular hypertension secondary to iTAA that does not respond to maximal medical treatment.
| Original language | English |
|---|---|
| Pages (from-to) | 756-757 |
| Number of pages | 2 |
| Journal | European Journal of Ophthalmology |
| Volume | 16 |
| Issue number | 5 |
| Publication status | Published - Sep 2006 |
Fingerprint
Keywords
- Argon laser trabeculoplasty
- Inraocular hypertension
- Triamcinolone
ASJC Scopus subject areas
- Ophthalmology
Cite this
Argon laser trabeculoplasty in triamcinolone acetonide induced ocular hypertension refractory to maximal medical treatment. / Ricci, F.; Missiroli, Filippo; Parravano, M.
In: European Journal of Ophthalmology, Vol. 16, No. 5, 09.2006, p. 756-757.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Argon laser trabeculoplasty in triamcinolone acetonide induced ocular hypertension refractory to maximal medical treatment
AU - Ricci, F.
AU - Missiroli, Filippo
AU - Parravano, M.
PY - 2006/9
Y1 - 2006/9
N2 - PURPOSE. To report two cases of intraocular hypertension after intravitreal injection of triamcinolone acetonide (iTAA) that were refractory to maximal medical therapy and were successfully treated with argon laser trabeculoplasty (ALT). METHODS. Two patients with history of primary open angle glaucoma were treated with intravitreal injection of triamcinolone acetonide for chronic macular edema secondary to branch retinal vein occlusion. Both patients (Case 1 after 2 months and Case 2 after 5 days) developed intraocular hypertension that did not respond to maximal medical therapy. Despite medical therapy, intraocular pressure (IOP) was 45 mmHg in Case 1 and between 34 and 37 mmHg in Case 2. ALT was performed in the inferior 180° angle using the following parameters: 50 μm size, 700 mW, 0.50 sec, 100 spots. RESULTS. In both patients IOP returned to normal level a few days after ALT. CONCLUSIONS. ALT seems to be effective at reducing IOP in patients with intraocular hypertension secondary to iTAA that does not respond to maximal medical treatment.
AB - PURPOSE. To report two cases of intraocular hypertension after intravitreal injection of triamcinolone acetonide (iTAA) that were refractory to maximal medical therapy and were successfully treated with argon laser trabeculoplasty (ALT). METHODS. Two patients with history of primary open angle glaucoma were treated with intravitreal injection of triamcinolone acetonide for chronic macular edema secondary to branch retinal vein occlusion. Both patients (Case 1 after 2 months and Case 2 after 5 days) developed intraocular hypertension that did not respond to maximal medical therapy. Despite medical therapy, intraocular pressure (IOP) was 45 mmHg in Case 1 and between 34 and 37 mmHg in Case 2. ALT was performed in the inferior 180° angle using the following parameters: 50 μm size, 700 mW, 0.50 sec, 100 spots. RESULTS. In both patients IOP returned to normal level a few days after ALT. CONCLUSIONS. ALT seems to be effective at reducing IOP in patients with intraocular hypertension secondary to iTAA that does not respond to maximal medical treatment.
KW - Argon laser trabeculoplasty
KW - Inraocular hypertension
KW - Triamcinolone
UR - http://www.scopus.com/inward/record.url?scp=33845312966&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33845312966&partnerID=8YFLogxK
M3 - Article
C2 - 17061231
AN - SCOPUS:33845312966
VL - 16
SP - 756
EP - 757
JO - European Journal of Ophthalmology
JF - European Journal of Ophthalmology
SN - 1120-6721
IS - 5
ER -